Comparative effectiveness of natalizumab, fingolimod, and first-line therapies for rapidly evolving severe relapsing-remitting multiple sclerosis | AVESİS

Karadeniz Technical University Research Information System

Comparative effectiveness of natalizumab, fingolimod, and first-line therapies for rapidly evolving severe relapsing-remitting multiple sclerosis

Copy For Citation

Spelman T., Acosta C., Hyde R., Campbell N., Havrdova E., Horakova D., ...More

8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 - 13 September 2020, vol.26, pp.526-527

Publication Type: Conference Paper / Summary Text
Volume: 26
Country: ELECTR NETWORK
Page Numbers: pp.526-527
Karadeniz Technical University Affiliated: Yes